| Concord Biotech Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543960 |
NSE Symbol : CONCORDBIO |
P/E(TTM) : 33.94 |
|
ISIN Demat : INE338H01029 |
Div & Yield% : 0.85 |
EPS(TTM) : 30.36 |
|
Book Value(₹) : 174.47 |
Market Cap(₹Cr) : 10,779.65 |
Face Value(₹) : 1.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 278.13 | 247.06 | 203.99 | 429.88 | 244.22 | 310.18 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 278.13 | 247.06 | 203.99 | 429.88 | 244.22 | 310.18 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 10.08 | 13.43 | 13.68 | 9.38 | 14.73 | 10.03 |
| Total Income | 288.22 | 260.49 | 217.67 | 439.27 | 258.95 | 320.21 |
| Total Expenditure | 179.19 | 156.52 | 142.59 | 239.46 | 146.27 | 173.50 |
| PBIDT | 109.03 | 103.97 | 75.07 | 199.81 | 112.68 | 146.70 |
| Interest | 0.06 | 0.06 | 0.06 | 0.10 | 0.10 | 0.10 |
| PBDT | 108.97 | 103.91 | 75.02 | 199.71 | 112.58 | 146.61 |
| Depreciation | 18.67 | 18.39 | 17.78 | 14.62 | 13.26 | 13.31 |
| Tax | 21.57 | 22.00 | 14.08 | 41.82 | 23.69 | 34.06 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.95 | 0.63 | 0.60 | 1.34 | 1.54 | 0.53 |
| Reported Profit After Tax | 67.78 | 62.90 | 42.57 | 141.94 | 74.09 | 98.70 |
| Extra-ordinary Items | -2.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 70.24 | 62.90 | 42.57 | 141.94 | 74.09 | 98.70 |
| EPS (Unit Curr.) | 6.48 | 6.01 | 4.07 | 13.57 | 7.08 | 9.43 |
| EPS (Adj) (Unit Curr.) | 6.48 | 6.01 | 4.07 | 13.57 | 7.08 | 9.43 |
| Calculated EPS (Unit Curr.) | 6.48 | 6.01 | 4.07 | 13.57 | 7.08 | 9.43 |
| Calculated EPS (Adj) (Unit Curr.) | 6.48 | 6.01 | 4.07 | 13.57 | 7.08 | 9.43 |
| Calculated EPS (Ann.) (Unit Curr.) | 25.92 | 24.05 | 16.27 | 54.27 | 28.33 | 37.74 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 25.92 | 24.05 | 16.27 | 54.27 | 28.33 | 37.74 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.46 | 10.46 | 10.46 | 10.46 | 10.46 | 10.46 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 39.20 | 42.08 | 36.80 | 46.48 | 46.14 | 47.30 |
| PBDTM(%) | 39.18 | 42.06 | 36.78 | 46.46 | 46.10 | 47.27 |
| PATM(%) | 24.37 | 25.46 | 20.87 | 33.02 | 30.34 | 31.82 |
